Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Tabelecleucel |
Trade Name | |
Synonyms | ATA129|ATA 129|EBV-CTL|Tab-cel |
Drug Descriptions |
Tabelecleucel (ATA129) is a preparation of donor-derived EBV-specific cytotoxic T-cells, which may decrease growth of EBV-positive tumors (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C143140 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + Tabelecleucel | Pembrolizumab Tabelecleucel | 0 | 1 |
Tabelecleucel | Tabelecleucel | 0 | 1 |